欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/0571/002
药品名称	Formoterol Novolizer 12 Mikrogramm
活性成分	formoterol 12.0 µg
剂型	Inhalation powder
上市许可持有人	Viatris Healthcare GmbH Lütticher Straße 5 53842 Troisdorf Germany
参考成员国 - 产品名称	Germany (DE)
互认成员国 - 产品名称	Belgium (BE) Netherlands (NL) Formoterol Novolizer 6 µg, inhalatiepoeder Luxembourg (LU) United Kingdom (Northern Ireland) (XI) Austria (AT) Novolizer Formoterol Meda 12 µg Pulver zur Inhalation France (FR) Spain (ES) Portugal (PT) Italy (IT)
许可日期	2006/03/03
最近更新日期	2024/01/31
药物ATC编码	R03AC13 formoterol
申请类型	TypeLevel1：Abridged TypeLevel2：Initial Application TypeLevel3：Other [Article 10.1.(a)(iii), last paragraph] TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final Product Information \| common-final-labop-0571(001)-V029Date of last change:2017/12/19 Final Product Information \| common-final-labop-0571(002)-V029Date of last change:2017/12/19 Final Product Information \| common-final-labop(refill)-0571(001)-V029Date of last change:2017/12/19 Final Product Information \| common-final-labop(refill)-0571(002)-V029Date of last change:2017/12/19 Final Product Information \| common-final-pl-0571(002)-V029Date of last change:2017/12/19 Final Product Information \| common-final-spc-0571(001)-V029Date of last change:2017/12/19 Final Product Information \| common-final-pl-0571(001)-V029Date of last change:2017/12/19 Final Product Information \| common-final-spc-0571(002)-V029Date of last change:2017/12/19
市场状态	Positive